Joseph W. LaPlume's most recent trade in Charles River Laboratories International Inc. was a trade of 385 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jun 2025 | 385 | 25,316 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 135.63 per share. | 30 May 2025 | 6,709 | 25,856 (0%) | 0% | 135.6 | 909,942 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.63 per share. | 30 May 2025 | 155 | 25,701 (0%) | 0% | 135.6 | 21,023 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.73 per share. | 26 May 2025 | 161 | 19,352 (0%) | 0% | 136.7 | 22,014 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.73 per share. | 26 May 2025 | 122 | 19,230 (0%) | 0% | 136.7 | 16,681 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 138.65 per share. | 26 May 2025 | 83 | 19,147 (0%) | 0% | 138.7 | 11,508 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 145.41 per share. | 13 May 2025 | 500 | 19,513 (0%) | 0% | 145.4 | 72,705 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 162.50 per share. | 20 Feb 2025 | 4,400 | 20,013 (0%) | 0% | 162.5 | 715,000 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 2,738 | 25,259 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.57 per share. | 31 Jan 2025 | 846 | 24,413 (0%) | 0% | 165.6 | 140,072 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 199.36 per share. | 08 Aug 2024 | 1,780 | 22,521 (0%) | 0% | 199.4 | 354,861 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2024 | 311 | 24,301 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 4,797 | 4,797 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 2,111 | 24,612 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.51 per share. | 29 May 2024 | 223 | 22,501 (0%) | 0% | 214.5 | 47,836 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 243 | 23,033 (0%) | 0% | 217.2 | 52,782 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 184 | 22,849 (0%) | 0% | 217.2 | 39,967 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 125 | 22,724 (0%) | 0% | 217.2 | 27,151 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 226.97 per share. | 10 May 2024 | 1,304 | 23,276 (0%) | 0% | 227.0 | 295,969 | Common Stock |
| Charles River Laboratories... | W. Joseph LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 238.93 per share. | 15 Feb 2024 | 838 | 24,620 (0%) | 0% | 238.9 | 200,223 | Common Stock |
| Charles River Laboratories... | LaPlume W. Joseph | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 3,350 | 26,483 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 3,279 | 26,412 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | LaPlume Joseph W. | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 220.28 per share. | 29 Jan 2024 | 1,025 | 25,458 (0%) | 0% | 220.3 | 225,787 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 220.28 per share. | 29 Jan 2024 | 994 | 25,418 (0%) | 0% | 220.3 | 218,958 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 197.73 per share. | 30 Nov 2023 | 1,850 | 23,133 (0%) | 0% | 197.7 | 365,801 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2023 | 9,128 | 0 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Exercise or conversion of derivative security received from the company (such as an option) at price $ 144.67 per share. | 09 Nov 2023 | 9,128 | 34,111 (0%) | 0% | 144.7 | 1,320,548 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 173.76 per share. | 09 Nov 2023 | 6,543 | 24,983 (0%) | 0% | 173.8 | 1,136,912 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 172.77 per share. | 09 Nov 2023 | 2,585 | 31,526 (0%) | 0% | 172.8 | 446,610 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 216.52 per share. | 10 Aug 2023 | 700 | 24,983 (0%) | 0% | 216.5 | 151,564 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 5,252 | 5,252 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 2,189 | 26,215 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.12 per share. | 26 May 2023 | 223 | 25,683 (0%) | 0% | 194.1 | 43,289 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.12 per share. | 26 May 2023 | 184 | 26,031 (0%) | 0% | 194.1 | 35,718 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.12 per share. | 26 May 2023 | 125 | 25,906 (0%) | 0% | 194.1 | 24,265 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 190.39 per share. | 15 May 2023 | 345 | 24,026 (0%) | 0% | 190.4 | 65,685 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 193.02 per share. | 12 May 2023 | 950 | 24,380 (0%) | 0% | 193.0 | 183,369 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 194.11 per share. | 12 May 2023 | 9 | 24,371 (0%) | 0% | 194.1 | 1,747 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 243.60 per share. | 22 Feb 2023 | 317 | 25,330 (0%) | 0% | 243.6 | 77,221 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 8,676 | 28,908 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.29 per share. | 27 Jan 2023 | 3,261 | 25,647 (0%) | 0% | 244.3 | 796,630 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 6,409 | 0 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.34 per share. | 01 Dec 2022 | 6,409 | 26,641 (0%) | 0% | 109.3 | 700,760 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 224.41 per share. | 01 Dec 2022 | 4,165 | 21,338 (0%) | 0% | 224.4 | 934,684 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 223.06 per share. | 01 Dec 2022 | 1,138 | 25,503 (0%) | 0% | 223.1 | 253,837 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 224.85 per share. | 01 Dec 2022 | 1,106 | 20,232 (0%) | 0% | 224.8 | 248,684 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 216.36 per share. | 04 Nov 2022 | 534 | 20,232 (0%) | 0% | 216.4 | 115,536 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 226.14 per share. | 06 Jul 2022 | 200 | 20,766 (0%) | 0% | 226.1 | 45,227 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jul 2022 | 195 | 20,966 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 4,478 | 4,478 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 1,657 | 21,509 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.41 per share. | 27 May 2022 | 223 | 21,161 (0%) | 0% | 244.4 | 54,503 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.41 per share. | 27 May 2022 | 125 | 21,384 (0%) | 0% | 244.4 | 30,551 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 292.75 per share. | 23 Feb 2022 | 395 | 19,852 (0%) | 0% | 292.7 | 115,636 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 291.80 per share. | 14 Feb 2022 | 1,143 | 21,275 (0%) | 0% | 291.8 | 333,527 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.05 per share. | 14 Feb 2022 | 743 | 22,418 (0%) | 0% | 88.0 | 65,421 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 743 | 0 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 290.83 per share. | 14 Feb 2022 | 392 | 20,562 (0%) | 0% | 290.8 | 114,007 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 293.61 per share. | 14 Feb 2022 | 317 | 20,958 (0%) | 0% | 293.6 | 93,074 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 289.58 per share. | 14 Feb 2022 | 315 | 20,247 (0%) | 0% | 289.6 | 91,218 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2022 | 150 | 21,675 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 290.75 per share. | 14 Feb 2022 | 4 | 20,954 (0%) | 0% | 290.8 | 1,163 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 11,344 | 26,395 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 312.24 per share. | 28 Jan 2022 | 4,570 | 21,825 (0%) | 0% | 312.2 | 1,426,937 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2021 | 6,771 | 15,051 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Nov 2021 | 182 | 8,280 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 400.91 per share. | 06 Aug 2021 | 1,458 | 10,704 (0%) | 0% | 400.9 | 584,522 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 402.43 per share. | 06 Aug 2021 | 1,042 | 8,762 (0%) | 0% | 402.4 | 419,335 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 401.66 per share. | 06 Aug 2021 | 900 | 9,804 (0%) | 0% | 401.7 | 361,498 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 409.40 per share. | 06 Aug 2021 | 300 | 8,462 (0%) | 0% | 409.4 | 122,820 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 3,476 | 3,476 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 1,124 | 12,385 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.99 per share. | 28 May 2021 | 223 | 12,162 (0%) | 0% | 338.0 | 75,372 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 281.41 per share. | 25 Feb 2021 | 4,334 | 13,650 (0%) | 0% | 281.4 | 1,219,643 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.05 per share. | 25 Feb 2021 | 2,750 | 19,996 (0%) | 0% | 88.1 | 242,138 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2021 | 2,750 | 743 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 280.75 per share. | 25 Feb 2021 | 2,012 | 17,984 (0%) | 0% | 280.8 | 564,877 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 283.50 per share. | 25 Feb 2021 | 1,422 | 11,261 (0%) | 0% | 283.5 | 403,144 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Sale of securities on an exchange or to another person at price $ 282.27 per share. | 25 Feb 2021 | 967 | 12,683 (0%) | 0% | 282.3 | 272,951 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 282.98 per share. | 24 Feb 2021 | 322 | 17,246 (0%) | 0% | 283.0 | 91,120 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 289.55 per share. | 22 Feb 2021 | 317 | 17,883 (0%) | 0% | 289.5 | 91,787 | Common Stock |
| Charles River Laboratories... | Joseph W. LaPlume | EVP, Corp Strategy & Develop | Payment of exercise price or tax liability using portion of securities received from the company at price $ 283.59 per share. | 22 Feb 2021 | 315 | 17,568 (0%) | 0% | 283.6 | 89,331 | Common Stock |